Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg ......

Oct 26, 2023

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg
GLIMITERIS TRIO 0.2  
Voglibose is an oral anti-diabetic medication that belongs to the class of drugs known as alpha-glucosidase inhibitors.
It is used to help control blood sugar levels in people with type 2 diabetes by slowing down the digestion and absorption of carbohydrates from the food you eat.
Voglibose works by inhibiting the enzymes in the small intestine that break down complex carbohydrates into simpler sugars, delaying the increase in blood glucose levels after meals.
Glimepiride is an oral anti-diabetic medication that belongs to the class of sulfonylureas.
It is used to lower blood sugar levels in people with type 2 diabetes by stimulating the pancreas to release more insulin.
Glimepiride works by increasing the release of insulin from the beta cells in the pancreas, which helps to lower blood sugar levels.
Metformin is another oral anti-diabetic medication, but it belongs to the biguanide class.
It is one of the most commonly prescribed drugs for the treatment of type 2 diabetes.
Metformin primarily works by reducing the amount of sugar produced by the liver and increasing the sensitivity of body tissues to insulin.
It does not increase insulin production but improves the body's use of insulin.
GLIMITERIS TRIO is available in strengths of 0.2mg and 0.3mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/glimiteris-trio-0-2-134376

SHARE WITH